Navigation Links
Veteran Pharmaceutical Executives Form New American Therapeutics, Inc.
Date:10/27/2010

CRANFORD, N.J., Oct. 27 /PRNewswire/ -- Alan L. Rubino, former Hoffmann-La Roche senior executive and former CEO of two emerging pharmaceutical companies, and Timothy G. Rothwell, former Chairman, CEO, and President of sanofi-aventis U.S., have collaborated to form New American Therapeutics, Inc.  

Mr. Rubino will serve as CEO and President, while Mr. Rothwell will function as the company's Chairman.  The company's key emphasis will be on establishing a general specialty pharmaceutical presence built around select physician specialties and associated patient therapeutic needs.

"The decision to start New American Therapeutics was driven by changing industry trends and market forces," said Mr. Rubino. "We saw an opportunity to create a new and agile business model that is flexible and versatile enough to navigate the challenges in today's dynamic environment. The industry experience and performance track records of our leaders, board members, and management team provide us with a keen understanding of what works and what doesn't."

New American Therapeutics is being funded through a partnership with Deerfield Management Company, L.P.   Deerfield is a privately owned healthcare investment management firm that was founded in 1994 and is based in New York, N.Y.  Piper Jaffray & Co. served as exclusive financial advisor to the company on its initial financing transaction.

On October 1, 2010, New American Therapeutics announced that it acquired all U.S. rights to manufacture, market and sell the topical antiviral drug Denavir® (www.denavir.com).  A proven treatment for cold sores since 1996, Denavir is the first product the company will be marketing and distributing.

"This was an opportunistic acquisition for us that met very specific criteria," explained Mr. Rubino. "It is an excellent therapeutic agent that, despite not receiving an adequate marketing investment, was still maintaining nearly a 50% prescription share of the topical antiviral market. That speaks volumes about physician and patient satisfaction."

Because of its current level of use in the marketplace coupled with a renewed commercial effort, Denavir is expected to provide a solid financial foundation for New American Therapeutics and will serve as the company's initial anchor product.

Beyond Denavir, New American Therapeutics will be pursuing marketed and launched assets that will benefit from the company's commercialization model. "Our progressive business strategy is already in the execution phase," said Mr. Rubino. "We will be tapping into our deep relationships within many U.S. and international pharmaceutical companies to explore product acquisition opportunities and other collaborations. We intend to move quickly and bring in products at a steady rate, which will allow us to grow in a rapid, yet calculated manner."

For more information about New American Therapeutics, visit www.natxcorp.com or call 908-282-7441.

About New American Therapeutics, Inc.New American Therapeutics, Inc. is a privately held general specialty pharmaceutical company based in Cranford, N.J. that acquires, markets and distributes products that have the potential to improve outcomes for patients and provide more treatment options for physicians. CONTACT:Alan L. Rubino  908-372-8108Email: arubino@natxcorp.com
'/>"/>

SOURCE New American Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Wound Management Technologies, Inc. Furthers its Government Initiatives and Business Development within the Veterans Health Administration
2. Prolong Pharmaceuticals Names Industry Veteran Glenn Kazo President
3. Medical Cannabis University™ Launches, Puts Thousands Back to Work to Help Veterans and the Chronically Ill
4. ZS Associates Appoints Pharmaceutical Industry Veteran to Serve the Firms Growing Client Base in Germany
5. Veteran Affairs Announces That Redsense Alarm Will be Mandatory on Patients by November 1, 2010
6. Veterans Administration Health Care System Purchases 15 Zargis Cardioscan Systems
7. Sperian Respiratory Protection USA Awarded a 65,000 Reusable Respirator Order by the Veterans Health Administration
8. Veteran International Health Care Executive Appointed CEO of BeneChill(R)
9. PTCB Certification Required for Pharmacy Technician Employment by Department of Veterans Affairs
10. Department of Veterans Affairs Requires PTCB Certification for Pharmacy Technician Employment
11. MyPunchbowl Expands Leadership Team With Veterans of Evite.com and Pizza Hut
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... May 4, 2016 ... the  "Global Acute Ischemic Stroke Market and ... their offering.       (Logo: ... Acute Ischemic Stroke Market and Competitive Landscape ... Ischemic Stroke pipeline products, Acute Ischemic Stroke ...
(Date:5/3/2016)... 2016 BioNovus Innovations LLC and the ... Medical Innovation (IAMI) today announced a new partnership ... medical devices. An agreement between the ... license, develop and commercialize medical innovations advanced through ... partnership represents a significant advance in our ability ...
(Date:5/3/2016)... LAKE OSWEGO, Ore. , May 3, 2016 ... and endovascular medical technology, today announced Food and ... a cardiac resynchronization defibrillator that provides heart failure ... (MRI) scans. Iperia devices also have remote monitoring ... (CLS) that adapts the heart rate in response ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... May 04, 2016 , ... AudioEducator is the country's top ... months, AudioEducator has lined up some informative training session for the medical coding ... compliance know-how and practical, easy-to-apply advice. , On Thursday, May 19, AudioEducator will ...
(Date:5/4/2016)... ... 2016 , ... Warren L. Smith M.D. , There is a new tool ... people since the beginning of recorded medical history, and in spite of all the ... just a matter of inconvenience; bladder infections cost us billions of dollars annually in ...
(Date:5/4/2016)... ... May 04, 2016 , ... Mediware Information ... therapy software application that helps blood and marrow transplant (BMT) programs meet compliance ... launch, Mediware has continued to enhance core application features. These enhancements are designed ...
(Date:5/4/2016)... ... May 04, 2016 , ... DESCO Medical ... Pocono Sterilizer, an equipment sterilization service and sales company located in Pennsylvania. The ... and research-related equipment and asset management services to the medical and academic research ...
(Date:5/4/2016)... ... ... Fertility Centers of New England announced today the opening of their newest location in ... to care for patients seeking fertility treatment in Maine. “We are delighted to partner ... said Fertility Centers of New England President and CEO, Joseph A. Hill, M.D. “Our ...
Breaking Medicine News(10 mins):